China National Medicines Corporation Ltd.
600511
Rang in aandelen
#4966
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Aandeelprijs
$3.90
Marktkapitalisatie
$2.94B
Verandering (1 dag)
-1.46%
Verandering (1 jaar)
-3.02%
Land
CN
Handel China National Medicines Corporation Ltd. (600511)
Categorie
Healthcare
Winst voor China National Medicines Corporation Ltd. (600511)
Winst in Jun 2026 TTM: $364.66M
Volgens de meest recente financiële verslagen van China National Medicines Corporation Ltd. bedraagt de huidige winst van het bedrijf $364.66M. In 2023 behaalde het bedrijf een winst van $414.05M, een stijging ten opzichte van de winst van 2022, die $389.67M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van China National Medicines Corporation Ltd. van 2000 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $364.66M | 0.30% |
| 2024 | $363.55M | -12.20% |
| 2023 | $414.05M | 6.26% |
| 2022 | $389.67M | 1.30% |
| 2021 | $384.65M | 31.06% |
| 2020 | $293.50M | -15.78% |
| 2019 | $348.48M | 18.48% |
| 2018 | $294.13M | 9.94% |
| 2017 | $267.54M | 18.23% |
| 2016 | $226.29M | 120.07% |
| 2015 | $102.83M | 1.91% |
| 2014 | $100.90M | 15.95% |
| 2013 | $87.02M | 28.00% |
| 2012 | $67.98M | 4.71% |
| 2011 | $64.92M | 26.10% |
| 2010 | $51.48M | 19.05% |
| 2009 | $43.24M | 17.69% |
| 2008 | $36.75M | 38.38% |
| 2007 | $26.56M | 79.82% |
| 2006 | $14.77M | 65.07% |
| 2005 | $8.95M | 30.75% |
| 2004 | $6.84M | 4.66% |
| 2003 | $6.54M | 21.97% |
| 2002 | $5.36M | 27.10% |
| 2001 | $4.22M | 35.00% |
| 2000 | $3.12M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $6.46B | 1,670.97% |
US
|
|
| - | - |
US
|
|
| $2.17B | 496.17% |
US
|
|
| - | - |
US
|
|
| $708.86M | 94.39% |
AU
|
